Israel’s DarioHealth has just received US FDA approval for the use by patients of their Dario self-test glucose monitors in hospitals. The aim is to reduce exposure of healthcare workers to coronavirus infected patients.

https://www.prnewswire.com/il/news-releases/dariohealth-self-test-blood-glucose-meters-can-now-be-utilized-within-hospitals-during-the-covid-19-pandemic-per-recently-issued-emergency-fda-guidelines-301053830.html